Paul A Gurbel Selected Research

6-chloro-2-(1-piperazinyl)pyrazine (CPP)

1/2018	Thrombogenicity and central pulse pressure to enhance prediction of ischemic event occurrence in patients with established coronary artery disease: The MAGMA-ischemia score.
8/2017	Central aortic pulse pressure, thrombogenicity and cardiovascular risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul A Gurbel Research Topics

Disease

73	Hemorrhage 05/2024 - 02/2007
67	Acute Coronary Syndrome 05/2024 - 12/2002
55	Thrombosis (Thrombus) 05/2024 - 02/2003
54	Coronary Artery Disease (Coronary Atherosclerosis) 12/2021 - 01/2003
51	Myocardial Infarction 05/2024 - 08/2002
28	Stroke (Strokes) 01/2024 - 01/2006
23	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 04/2005
16	Inflammation (Inflammations) 06/2023 - 01/2006
15	COVID-19 03/2023 - 01/2020
11	Heart Failure 03/2024 - 01/2002
10	Atherosclerosis 01/2021 - 05/2015
8	Peripheral Arterial Disease 11/2020 - 06/2015
7	Ischemic Stroke 12/2023 - 03/2008
7	Ischemia 02/2022 - 01/2006
7	ST Elevation Myocardial Infarction 01/2021 - 01/2012
6	Diabetes Mellitus 03/2024 - 04/2005
6	Thrombophilia 12/2022 - 02/2014
5	Atrial Fibrillation 10/2021 - 07/2011
5	Thromboembolism 01/2018 - 03/2008
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2023 - 10/2011
4	Unstable Angina 11/2012 - 12/2002
3	Vascular Diseases (Vascular Disease) 10/2022 - 12/2016
3	Dyspnea (Shortness of Breath) 01/2022 - 07/2010
3	Necrosis 12/2020 - 03/2005
3	Pathologic Constriction (Stenosis) 01/2018 - 04/2016
3	Infarction (Infarctions) 01/2017 - 10/2002
3	Type 2 Diabetes Mellitus (MODY) 12/2016 - 11/2009
3	Transient Ischemic Attack 06/2015 - 08/2012
3	Coronary Disease (Coronary Heart Disease) 01/2013 - 01/2003
2	Heart Arrest (Cardiac Arrest) 11/2023 - 10/2020
2	MINOCA 01/2023 - 12/2022
2	Pneumonia (Pneumonitis) 01/2023 - 04/2015
2	Thrombocytopenia (Thrombopenia) 01/2022 - 08/2018
2	Death (Near-Death Experience) 12/2021 - 04/2005
2	Venous Thrombosis (Deep-Vein Thrombosis) 10/2021 - 09/2013
2	Hypersensitivity (Allergy) 01/2017 - 09/2011
2	Dyslipidemias (Dyslipidemia) 05/2016 - 07/2015

Drug/Important Bio-Agent (IBA)

88	Clopidogrel (Plavix)FDA Link 12/2023 - 02/2003
70	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2023 - 06/2002
20	Prasugrel Hydrochloride FDA Link 12/2023 - 03/2008
19	Adenosine Diphosphate (ADP)IBA 01/2021 - 06/2002
17	TicagrelorIBA 01/2022 - 12/2009
12	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 05/2024 - 01/2010
12	omega-Chloroacetophenone (Mace)IBA 03/2024 - 04/2016
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2002
11	AnticoagulantsIBA 10/2021 - 07/2011
11	Thrombin FDA Link 11/2020 - 05/2006
10	FibrinIBA 12/2021 - 05/2006
8	Cytochrome P-450 CYP2C19IBA 11/2023 - 12/2010
7	LipidsIBA 06/2018 - 01/2006
7	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2015 - 10/2005
5	C-Reactive ProteinIBA 06/2023 - 03/2004
5	vorapaxarIBA 01/2020 - 10/2011
5	Warfarin (Coumadin)FDA LinkGeneric 10/2018 - 07/2011
5	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2018 - 04/2003
4	Proprotein Convertase 9IBA 01/2023 - 07/2015
4	Platelet Membrane Glycoprotein IIbIBA 08/2022 - 12/2002
4	Glycoproteins (Glycoprotein)IBA 08/2018 - 01/2005
4	Phenobarbital (Luminal)FDA Link 01/2018 - 04/2013
4	thienopyridineIBA 04/2017 - 12/2006
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016 - 03/2004
3	Oxygen (Dioxygen)IBA 11/2023 - 01/2023
3	Fibrinogen (Factor I)FDA Link 01/2022 - 01/2021
3	Metalloproteases (Metalloproteinases)IBA 01/2021 - 01/2008
3	AntibodiesIBA 12/2020 - 07/2015
3	EnzymesIBA 06/2018 - 10/2007
3	oxidized low density lipoproteinIBA 01/2018 - 01/2006
3	bivalirudin (Angiomax)FDA Link 01/2018 - 02/2009
3	Purinergic P2Y Receptor AntagonistsIBA 04/2017 - 03/2010
3	Proton Pump InhibitorsIBA 09/2014 - 01/2010
3	Eptifibatide (Integrilin)FDA Link 02/2009 - 12/2002
2	Fatty Acid-Binding ProteinsIBA 03/2023 - 07/2021
2	sirioIBA 01/2023 - 01/2022
2	Estrogens (Estrogen)FDA Link 12/2022 - 01/2013
2	fibrin fragment D (D-dimer)IBA 01/2022 - 01/2021
2	11-dehydro-thromboxane B2IBA 07/2021 - 01/2020
2	RivaroxabanIBA 01/2020 - 01/2018
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2019 - 10/2007
2	Hemoglobins (Hemoglobin)IBA 10/2018 - 06/2016
2	CSL112IBA 05/2018 - 08/2015
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 05/2018 - 08/2015
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2018 - 08/2017
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2017 - 05/2010
2	LDL Lipoproteins (beta Lipoproteins)IBA 11/2017 - 01/2006
2	TabletsIBA 01/2017 - 09/2014
2	Genetic Markers (Genetic Marker)IBA 04/2016 - 05/2015
2	AntithrombinsIBA 12/2015 - 09/2013
2	P-SelectinIBA 04/2015 - 06/2009
2	Cilostazol (Pletal)FDA LinkGeneric 01/2015 - 11/2012
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2012 - 10/2007
2	Sirolimus (Rapamycin)FDA Link 11/2011 - 12/2006

Therapy/Procedure

107	Therapeutics 05/2024 - 06/2002
53	Percutaneous Coronary Intervention 05/2024 - 01/2006
37	Stents 05/2024 - 10/2002
10	Secondary Prevention 01/2020 - 08/2012
7	Drug-Eluting Stents 01/2020 - 01/2007
6	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2018 - 08/2011
3	Drug Therapy (Chemotherapy) 10/2020 - 08/2013
2	Length of Stay 12/2023 - 02/2007
2	Heart-Assist Devices 11/2018 - 11/2017